Cofinimmo Valuation
Is COFBB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of COFBB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: COFBB (€65.78) is trading below our estimate of fair value (€87.48)
Significantly Below Fair Value: COFBB is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for COFBB?
Key metric: As COFBB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is COFBB's PS Ratio? | |
|---|---|
| PS Ratio | 5.9x |
| Sales | €391.77m |
| Market Cap | €2.30b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 13.2x |
| Enterprise Value/EBITDA | 18.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does COFBB's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.2x | ||
AGR Assura | 7.6x | 4.8% | UK£1.3b |
PHP Primary Health Properties | 7.1x | -0.4% | UK£1.3b |
THRL Target Healthcare REIT | 7.5x | 3.2% | UK£522.9m |
CRT Care REIT | 6.5x | 6.0% | UK£348.1m |
COFBB Cofinimmo | 5.9x | -1.7% | €2.3b |
Price-To-Sales vs Peers: COFBB is good value based on its Price-To-Sales Ratio (5.9x) compared to the peer average (7.4x).
Price to Sales Ratio vs Industry
How does COFBB's PS Ratio compare vs other companies in the Global Health Care REITs Industry?
| 4 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 4 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: COFBB is good value based on its Price-To-Sales Ratio (5.9x) compared to the Global Health Care REITs industry average (6.9x).
Price to Sales Ratio vs Fair Ratio
What is COFBB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 5.9x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate COFBB's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Cofinimmo
€2.1b
Cofinimmo has been acquiring, developing and managing rental properties for 40 years.
0J3X
€56.26
7D
-1.6%
1Y
-13.1%
Xior Student Housing
€1.3b
Xior Student Housing NV is the first Belgian public regulated real estate company (RREC) specialising in the student housing segment in Belgium, the Netherlands, Spain, Portugal, Germany, Poland, Denmark and Sweden.
0RD8
€30.55
7D
1.0%
1Y
-1.7%
Mercialys
€996.2m
Mercialys is one of France’s leading real estate companies.
MERYP
€10.54
7D
0%
1Y
n/a